Literature DB >> 24566888

Performance characteristics of broth-only cultures after revision total joint arthroplasty.

Eric B Smith1, Jenny Cai, Rachael Wynne, Mitchell Maltenfort, Robert P Good.   

Abstract

BACKGROUND: Surgeons frequently obtain intraoperative cultures at the time of revision total joint arthroplasty. The use of broth or liquid medium before applying the sample to the agar medium may be associated with contamination and false-positive cultures; however, the degree to which this is the case is not known. QUESTIONS/PURPOSES: We (1) calculated the performance characteristics of broth-only cultures (sensitivity, specificity, positive predictive value, and negative predictive value) and (2) characterized the organisms identified in broth to determine whether a specific organism showed increased proclivity for true-positive periprosthetic joint infection (PJI).
METHODS: A single-institution retrospective chart review was performed on 257 revision total joint arthroplasties from 2009 through 2010. One hundred ninety (74%) had cultures for review. All culture results, as well as treatment, if any, were documented and patients were followed for a minimum of 1 year for evidence of PJI. Cultures were measured as either positive from the broth only or broth negative. The true diagnosis of infection was determined by the Musculoskeletal Infection Society criteria during the preoperative workup or postoperatively at 1 year for purposes of calculating the performance characteristics of the broth-only culture.
RESULTS: The sensitivity, specificity, positive predictive value, and negative predictive value were 19%, 88%, 13%, and 92%, respectively. The most common organism identified was coagulase-negative Staphylococcus (16 of 24 cases, 67%). Coagulase-negative Staphylococcus was present in all three true-positive cases; however, it was also found in 13 of the false-positive cases.
CONCLUSIONS: The broth-only positive cultures showed poor sensitivity and positive predictive value but good specificity and negative predictive value. The good specificity indicates that it can help to rule in the presence of PJI; however, the poor sensitivity makes broth-only culture an unreliable screening test. We recommend that broth-only culture results be carefully scrutinized and decisions on the diagnosis and treatment of infection should be based specifically on the Musculoskeletal Infection Society criteria. LEVEL OF EVIDENCE: Level IV, diagnostic study. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24566888      PMCID: PMC4182409          DOI: 10.1007/s11999-014-3507-z

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  22 in total

1.  Use of blood culture vial specimens in intraoperative detection of infection.

Authors:  B R Levine; B G Evans
Journal:  Clin Orthop Relat Res       Date:  2001-01       Impact factor: 4.176

2.  Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance.

Authors:  S Harbarth; M H Samore; D Lichtenberg; Y Carmeli
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

Review 3.  Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature review.

Authors:  Louis Bernard; Anne Lübbeke; Richard Stern; Jean Pierre Bru; Jean Marc Feron; Dominique Peyramond; Philippe Denormandie; Cedric Arvieux; Catherine Chirouze; Christian Perronne; Pierre Hoffmeyer
Journal:  Scand J Infect Dis       Date:  2004

4.  New definition for periprosthetic joint infection.

Authors: 
Journal:  J Arthroplasty       Date:  2011-12       Impact factor: 4.757

Review 5.  [Microbiological diagnosis of bone-joint infections].

Authors:  Mercedes Marín; Jaime Esteban; María Antonia Meseguer; Mar Sánchez-Somolinos
Journal:  Enferm Infecc Microbiol Clin       Date:  2010-10       Impact factor: 1.731

6.  Diagnosis of periprosthetic joint infections of the hip and knee.

Authors:  Craig Della Valle; Javad Parvizi; Thomas W Bauer; Paul E Dicesare; Richard Parker Evans; John Segreti; Mark Spangehl; William C Watters; Michael Keith; Charles M Turkelson; Janet L Wies; Patrick Sluka; Kristin Hitchcock
Journal:  J Am Acad Orthop Surg       Date:  2010-12       Impact factor: 3.020

7.  Diagnosing periprosthetic infection: false-positive intraoperative Gram stains.

Authors:  Margret Oethinger; Debra K Warner; Susan A Schindler; Hideo Kobayashi; Thomas W Bauer
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

8.  Gram stains have limited application in the diagnosis of infected total knee arthroplasty.

Authors:  Michael G Zywiel; D Alex Stroh; Aaron J Johnson; David R Marker; Michael A Mont
Journal:  Int J Infect Dis       Date:  2011-07-20       Impact factor: 3.623

Review 9.  Diagnosis of periprosthetic infection.

Authors:  Thomas W Bauer; Javad Parvizi; Naomi Kobayashi; Viktor Krebs
Journal:  J Bone Joint Surg Am       Date:  2006-04       Impact factor: 5.284

10.  Periprosthetic infection: where do we stand with regard to Gram stain?

Authors:  Elie Ghanem; Constantinos Ketonis; Camilo Restrepo; Ashish Joshi; Robert Barrack; Javad Parvizi
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more
  2 in total

Review 1.  The role of biofilm on orthopaedic implants: the "Holy Grail" of post-traumatic infection management?

Authors:  C Mauffrey; B Herbert; H Young; M L Wilson; M Hake; P F Stahel
Journal:  Eur J Trauma Emerg Surg       Date:  2016-06-04       Impact factor: 3.693

2.  Comparative meta-omics for identifying pathogens associated with prosthetic joint infection.

Authors:  Karan Goswami; Alexander J Shope; Vasily Tokarev; Justin R Wright; Lavinia V Unverdorben; Truc Ly; Jeremy Chen See; Christopher J McLimans; Hoi Tong Wong; Lauren Lock; Samuel Clarkson; Javad Parvizi; Regina Lamendella
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.